American Cancer Society Family of Journals,
Romiplostim increases platelet counts and decreases bleeding events and platelet transfusions in patients... Romiplostim…
Results of a randomized, double‐blind study of romiplostim versus placebo in patients with low/intermediate‐1–risk myelodysplastic syndrome and thrombocytopenia
Overview of attention for article published in Cancer (0008543X), April 2014
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (90th percentile)
-
Good Attention Score compared to outputs of the same age and source (76th percentile)
Readers on
- mendeley
- 91 Mendeley